New Article Reviews State of Clinical Trial Enrollment from Non-White Patients
Dec 19, 2022
ObvioHealth, a leading virtual clinical trial platform, proposes solutions for increasing clinical trial enrollment from patients in Indigenous, Black, and non-white communities.
New York,United States - December 19, 2022 /PressCable/ —
Decentralized clinical trial pioneer, ObvioHealth, recently posted a new article discussing the difference between white and non-white participation in clinical trials.
To understand the reason for this disparity, the company delved into the history of trauma that led to a distrust of the medical profession among ethnic groups.
One of the first points raised by the Virtual Research Organization (VRO) was the unethical and dangerous medical studies certain groups were subjected to without their knowledge or consent in the past.
Problems of language, culture, and religion have also contributed to the lack of participation, claims the company.
Finally, there are practical reasons, such as the inability to travel to the trial site due to a lack of job security, making people reluctant to leave work.
Regardless of reasons, this lack of trial participation goes on to create a disparity in medical outcomes, claims the company. One of the examples provided was enrollment in cancer trials.
The company explains that, in the U.S., death rates due to cancer have increased among the Native American and Alaskan Native populations in the last three decades. However, their participation in trials has declined.
Similarly, other ethnic minorities are also poorly represented. Even though 14% of the American population is Black, a 2015 cancer study only had 1.8% participation from that group.
This becomes even more problematic since 20% of the patients diagnosed with myeloma in the U.S. are Black, observes ObvioHealth.
When it comes to blood cancer, Black Americans represent an insignificant percentage of trial participants, even though they are twice as likely to be diagnosed with it than white Americans.
On the face of it, this might not seem like a problem, especially if there are enough trial participants. However, the fact is, treatment efficacy can vary among different population types, says the company. Symptoms, treatments, and side effects may differ based on a patient’s genetic markers.
Therefore, according to the VRO, representation in clinical trials is essential for the development of treatments that work effectively across ethnic groups.
The company pointed out similar discrepancies in trial participation in Australia, where 1.5% clinical trials focused on Aboriginal health.
Again, this lack of wider participation means that long-term medical problems cannot be identified in minority groups, states ObvioHealth. Also, potential issues cannot be identified early in the process of developing a treatment.
To fix this issue, ObvioHealth suggests that there needs to be efforts made to rebuild trust. That entails improving communications and transparency and actively engaging community members in the research process.
The VRO provided the example of indigenous people and how engaging community members might mean storing biological samples on sovereign indigenous land, and ensuring they are made available only to researchers who prioritize their needs.
Another important step, according to the company, might be to provide them with a research environment that feels emotionally and physically safe. Improving access, too, will help boost Indigenous and minority participation rates.
To that end, virtual enrollment might help create an inclusive environment, where the hurdle of geographical distance is eliminated. It also helps give participants more privacy, encouraging them to take part in trials for what might be considered taboo diseases and disorders.
Finally, virtual participation also helps in communication and transparency, claims ObvioHealth. With technological advances in remote patient monitoring and sophisticated remote telemedicine, virtual clinical trials are the answer to encouraging diversity in medical research.
ObvioHealth’s platform enables decentralized clinical trials through comprehensive and patient-friendly features. To view what the software offers, please visit https://www.obviohealth.com/
Contact Info:
Name: James Hendrick
Email: Send Email
Organization: ObvioHealth USA, Inc.
Address: 545 West 25th Street 20th Floor , New York, NY 10001, United States
Phone: +1-888-880-1664
Website: https://www.obviohealth.com/
Source: PressCable
Release ID: 89086185
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 8 hours.
More News
Charity expects demand for Christmas present campaign
The campaign, run by Little Stars, is running from today until 4 December.
Monet Painting Sells for $56 Million in France
The artwork, titled “Iris,” is among the painter’s later works, which wealthy collectors have coveted in recent years.
Fearing Mass A.I. Layoffs, Some in Congress Eye Ways to Aid Workers
A bill to bolster the nation’s unemployment insurance program reflects the concern — and the risks — in Washington.
White House lifts tariffs on some Canadian goods as midterm elections loom
From 30 October, tariffs will be eased on some products, including certain machinery, and placed on others, such as carpets.
How does the UK state pension compare with other countries?
Do British pensioners have it better or worse than those in other countries?
UK to invest £100m in 'world first' AI Biosecurity Lab
The chancellor will unveil AI spending aimed at shoring up the UK's defences in Wednesday's Budget.
Before you crank up the thermostat, try these tips to keep you and your home warmer for longer
With storms hitting parts of the UK and the clocks going back, here are some practical ways to cope with falling temperatures.
France’s Avoids a Debt Downgrade From Moody’s, but Is Given a Warning
Moody’s held the country’s credit rating steady amid political uncertainty and a rise in borrowing costs that have worsened France’s debt situation.
A Simple Way to Benefit From Rising Rates: Buy Money Market Funds
While higher interest rates are a complication for stocks and bonds, they are an unequivocal boon if you just want to park some cash and make a little money, our columnist says.
Ahead of Tight Race, Trump Swaps Tariffs on Some Canadian Goods
The move was announced by Senator Susan Collins, a Maine Republican who faces a tough re-election fight amid rising prices.
Global Oil Price Hits $116 a Barrel, Highest Since April
Investors have grown increasingly concerned that the war in Iran could escalate again, putting energy supplies at greater risk.
How Worried Should We Be About the Economy? Let’s Look at 2008.
It’s not impossible to spot the characteristics of a brewing financial crisis. We can look to 2008 for clues.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.